S&P 500 4,577.11 (-1.84%)

DOW 35,368.47 (-1.51%)

QQQ 370.55 (-2.49%)

AAPL 169.80 (-1.89%)

MSFT 302.65 (-2.43%)

FB 318.15 (-4.14%)

GOOGL 2,719.96 (-2.50%)

AMZN 3,178.35 (-1.99%)

TSLA 1,030.51 (-1.82%)

NVDA 259.03 (-3.86%)

BABA 128.60 (-2.26%)

NIO 29.61 (-4.33%)

AMD 131.93 (-3.62%)

CGC 7.78 (-7.38%)

MU 92.87 (-4.61%)

GE 102.89 (-0.26%)

T 27.31 (+0.48%)

F 24.38 (-3.22%)

DIS 152.27 (+0.22%)

AMC 18.84 (-8.41%)

PFE 54.11 (-1.53%)

ACB 5.11 (-7.26%)

BA 225.01 (-0.42%)

S&P 500 4,577.11 (-1.84%)

DOW 35,368.47 (-1.51%)

QQQ 370.55 (-2.49%)

AAPL 169.80 (-1.89%)

MSFT 302.65 (-2.43%)

FB 318.15 (-4.14%)

GOOGL 2,719.96 (-2.50%)

AMZN 3,178.35 (-1.99%)

TSLA 1,030.51 (-1.82%)

NVDA 259.03 (-3.86%)

BABA 128.60 (-2.26%)

NIO 29.61 (-4.33%)

AMD 131.93 (-3.62%)

CGC 7.78 (-7.38%)

MU 92.87 (-4.61%)

GE 102.89 (-0.26%)

T 27.31 (+0.48%)

F 24.38 (-3.22%)

DIS 152.27 (+0.22%)

AMC 18.84 (-8.41%)

PFE 54.11 (-1.53%)

ACB 5.11 (-7.26%)

BA 225.01 (-0.42%)

S&P 500 4,577.11 (-1.84%)

DOW 35,368.47 (-1.51%)

QQQ 370.55 (-2.49%)

AAPL 169.80 (-1.89%)

MSFT 302.65 (-2.43%)

FB 318.15 (-4.14%)

GOOGL 2,719.96 (-2.50%)

AMZN 3,178.35 (-1.99%)

TSLA 1,030.51 (-1.82%)

NVDA 259.03 (-3.86%)

BABA 128.60 (-2.26%)

NIO 29.61 (-4.33%)

AMD 131.93 (-3.62%)

CGC 7.78 (-7.38%)

MU 92.87 (-4.61%)

GE 102.89 (-0.26%)

T 27.31 (+0.48%)

F 24.38 (-3.22%)

DIS 152.27 (+0.22%)

AMC 18.84 (-8.41%)

PFE 54.11 (-1.53%)

ACB 5.11 (-7.26%)

BA 225.01 (-0.42%)

S&P 500 4,577.11 (-1.84%)

DOW 35,368.47 (-1.51%)

QQQ 370.55 (-2.49%)

AAPL 169.80 (-1.89%)

MSFT 302.65 (-2.43%)

FB 318.15 (-4.14%)

GOOGL 2,719.96 (-2.50%)

AMZN 3,178.35 (-1.99%)

TSLA 1,030.51 (-1.82%)

NVDA 259.03 (-3.86%)

BABA 128.60 (-2.26%)

NIO 29.61 (-4.33%)

AMD 131.93 (-3.62%)

CGC 7.78 (-7.38%)

MU 92.87 (-4.61%)

GE 102.89 (-0.26%)

T 27.31 (+0.48%)

F 24.38 (-3.22%)

DIS 152.27 (+0.22%)

AMC 18.84 (-8.41%)

PFE 54.11 (-1.53%)

ACB 5.11 (-7.26%)

BA 225.01 (-0.42%)

Shore Capital Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Shore Capital
Rating: 2.8
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Shore Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Shore Capital.

Company	Date	Action	Brokerage	Rating	Impact on Price
GSK GlaxoSmithKline	2/12/2020	Downgraded by	Shore Capital	Hold -> Sell	Low
GSK GlaxoSmithKline	3/8/2019	Downgraded by	Shore Capital	Buy -> Hold	Low
GSK GlaxoSmithKline	7/27/2018	Upgraded by	Shore Capital	Hold -> Buy	Low
AZN AstraZeneca	11/10/2016	Reiterated by	Shore Capital	Hold	N/A
JHS John Hancock Income Securities Trust	10/10/2016	Reiterated by	Shore Capital	Buy	N/A
AZN AstraZeneca	10/8/2016	Reiterated by	Shore Capital	Hold	N/A
NWG NatWest Group	9/28/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	9/28/2016	Reiterated by	Shore Capital	Hold	N/A
JHS John Hancock Income Securities Trust	9/14/2016	Reiterated by	Shore Capital	Buy	N/A
AZN AstraZeneca	9/3/2016	Reiterated by	Shore Capital	Hold	N/A
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
GSK GlaxoSmithKline	8/17/2016	Reiterated by	Shore Capital	Hold	N/A
GSK GlaxoSmithKline	8/11/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	8/10/2016	Reiterated by	Shore Capital	Hold	N/A
QCLN First Trust NASDAQ Clean Edge Green Energy Index Fund	8/6/2016	Reiterated by	Shore Capital	Buy	N/A
BCS Barclays	8/1/2016	Reiterated by	Shore Capital	Buy	N/A
PSO Pearson	7/31/2016	Reiterated by	Shore Capital	Hold	N/A
GSK GlaxoSmithKline	7/27/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	7/27/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	7/20/2016	Reiterated by	Shore Capital	Hold	N/A
JHS John Hancock Income Securities Trust	7/19/2016	Reiterated by	Shore Capital	Buy	N/A
GSK GlaxoSmithKline	7/19/2016	Reiterated by	Shore Capital	Hold	N/A
QCLN First Trust NASDAQ Clean Edge Green Energy Index Fund	6/29/2016	Reiterated by	Shore Capital	Buy	N/A
PROV Provident Financial	6/25/2016	Reiterated by	Shore Capital	Hold	N/A
PSO Pearson	6/21/2016	Reiterated by	Shore Capital	Hold	N/A
GSK GlaxoSmithKline	6/21/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	6/14/2016	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	5/17/2016	Reiterated by	Shore Capital	Hold	N/A
BCS Barclays	3/1/2016	Reiterated by	Shore Capital	Hold	N/A
PROV Provident Financial	2/23/2016	Reiterated by	Shore Capital	Hold	N/A
HSBC HSBC	2/23/2016	Reiterated by	Shore Capital	Sell	N/A
NWG NatWest Group	1/27/2016	Reiterated by	Shore Capital	Buy	N/A
UL Unilever	1/19/2016	Reiterated by	Shore Capital	Buy	N/A
PROV Provident Financial	1/13/2016	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	11/12/2015	Reiterated by	Shore Capital	Hold	N/A
LYG Lloyds Banking Group	10/30/2015	Upgraded by	Shore Capital	Buy	N/A
BCS Barclays	10/28/2015	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	9/23/2015	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	9/17/2015	Reiterated by	Shore Capital	Hold	N/A
BCS Barclays	8/13/2015	Downgraded by	Shore Capital	Hold	N/A
NWG NatWest Group	7/29/2015	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	7/3/2015	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	6/8/2015	Reiterated by	Shore Capital	Hold	N/A
AZN AstraZeneca	4/13/2015	Reiterated by	Shore Capital	Buy	N/A
GSK GlaxoSmithKline	3/20/2015	Reiterated by	Shore Capital	Buy	N/A
AZN AstraZeneca	3/16/2015	Reiterated by	Shore Capital	Buy	N/A
PUK Prudential	3/10/2015	Reiterated by	Shore Capital	Buy	N/A
BCS Barclays	3/3/2015	Reiterated by	Shore Capital	Buy	N/A
GSK GlaxoSmithKline	2/6/2015	Reiterated by	Shore Capital	Buy	N/A
AZN AstraZeneca	1/27/2015	Reiterated by	Shore Capital	Buy	N/A
UL Unilever	1/20/2015	Reiterated by	Shore Capital	Buy	N/A

DEO Diageo	12/18/2014	Reiterated by	Shore Capital	Hold	N/A
LYG Lloyds Banking Group	12/16/2014	Reiterated by	Shore Capital	Hold	N/A
HSBC HSBC	12/16/2014	Reiterated by	Shore Capital	Hold	N/A
BCS Barclays	12/16/2014	Reiterated by	Shore Capital	Buy	N/A
CCL Carnival Co. &	9/12/2014	Upgraded by	Shore Capital	Hold -> Buy	N/A
GSK GlaxoSmithKline	4/28/2014	Reiterated by	Shore Capital	Buy	N/A
ABM ABM Industries	10/2/2013	Reiterated by	Shore Capital	Sell -> Sell	N/A
HSBC HSBC	7/3/2013	Reiterated by	Shore Capital	Buy	N/A
BCS Barclays	7/3/2013	Reiterated by	Shore Capital	Buy	N/A
BCS Barclays	6/13/2013	Reiterated by	Shore Capital	Buy	N/A
ABM ABM Industries	5/28/2013	Reiterated by	Shore Capital	Sell	N/A
BCS Barclays	5/23/2013	Reiterated by	Shore Capital	Buy	N/A
UL Unilever	4/26/2013	Reiterated by	Shore Capital	Buy	N/A
DEO Diageo	4/26/2013	Reiterated by	Shore Capital	Buy	N/A
ALB Albemarle	4/22/2013	Reiterated by	Shore Capital	Sell	N/A
ABM ABM Industries	4/22/2013	Reiterated by	Shore Capital	Sell -> Sell	N/A
IHG InterContinental Hotels Group	3/28/2013	Reiterated by	Shore Capital	Sell	N/A
BWXT BWX Technologies	3/26/2013	Reiterated by	Shore Capital	Hold	N/A
DEO Diageo	3/22/2013	Reiterated by	Shore Capital	Buy	N/A
HSBC HSBC	3/19/2013	Upgraded by	Shore Capital	Buy	N/A

MarketBeat Community Rating for Shore Capital

Community Ranking:		2.8 out of 5 ( )
Outperform Votes:		17,742 (Vote Outperform)
Underperform Votes:		14,125 (Vote Underperform)
Total Votes:		31,867

MarketBeat's community ratings are surveys of what our community members think about Shore Capital and other research firms. Vote "Outperform" if you believe Shore Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Shore Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

See Also:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here